Affordable medicines for all Australians
Pharmaceutical Benefits Scheme (PBS) (pbs.gov.au) scores 69 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 20th percentile of 10159 Healthcare brands.
The Pharmaceutical Benefits Scheme (PBS) is an Australian Government program that subsidises the cost of a wide range of prescription medicines, making them more affordable for Australian residents. It provides a searchable, authoritative schedule of subsidised medicines with pricing and listing information, serving patients, healthcare professionals, pharmacists, and medicine manufacturers. As a government initiative, it acts as the official source for medicine subsidy status and updates in Australia.
| Brand Name | Pharmaceutical Benefits Scheme (PBS) |
|---|---|
| Domain | pbs.gov.au |
| Industry | Healthcare, Government |
| Parent Company / Owner | Australian Government |
| Main Competitors | PHARMAC (New Zealand), NHS Prescription Services (74/100), Medicare Part D (U.S. Centers for Medicare & Medicaid Services) (87/100) |
Moz Domain Authority 53/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #153,032 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Pharmaceutical Benefits Scheme (PBS) has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Pharmaceutical Benefits Scheme (PBS)" (Meta description too short (4 words). OG description present but brief) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Pharmaceutical Benefits Scheme (PBS)?", Claude could identify the brand as of September 2026. The Pharmaceutical Benefits Scheme (PBS) is an Australian government program that subsidizes the cost of a wide range of prescription medicines for residents, making essential drugs more affordable. It's administered by the Australian Department of Health and lists medicines that Best known for Subsidizing prescription medicine costs for Australian residents through a government-listed formulary.
When asked "Best brands similar to Pharmaceutical Benefits Scheme (PBS)?", Claude would recommend Pharmaceutical Benefits Scheme (PBS) as of September 2026. If someone asks about drug subsidy or national pharmaceutical coverage schemes, PBS is a standout example of a well-run public health program worth mentioning.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Pharmaceutical Benefits Scheme (PBS)'s main competitors in Healthcare: NHS Prescription Services (74/100), Medicare Part D (U.S. Centers for Medicare & Medicaid Services) (87/100).
Sources: Brand Analyzer scan
Yes, the PBS is an official Australian Government initiative, making it an authoritative and trustworthy source for information on subsidised medicine listings, pricing, and status updates.
The PBS offers a searchable schedule of subsidised prescription medicines, including current listing information, subsidised pricing, and status updates, available to patients, healthcare professionals, pharmacists, and medicine manufacturers.
The Pharmaceutical Benefits Scheme (PBS) is an Australian Government initiative that subsidises the cost of a wide range of prescription medicines. It functions as the official, authoritative source for information on which medicines are subsidised, their pricing, and their listing status in Australia.
Pharmaceutical Benefits Scheme (PBS) has limited AI-search visibility, scoring 48/100 on Brand Analyzer's AI visibility composite (visibility 58, trust 26, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Pharmaceutical Benefits Scheme (PBS) scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
The PBS is known for making prescription medicines affordable for Australians by subsidising their cost through a government-run scheme, and for maintaining a transparent, publicly searchable schedule of subsidised medicines.
Pharmaceutical Benefits Scheme (PBS) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
The PBS is used by Australian residents seeking affordable prescription medicines, as well as healthcare professionals, pharmacists, and medicine manufacturers who need information on subsidised medicine listings and pricing.
Pharmaceutical Benefits Scheme (PBS) scores 48/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Pharmaceutical Benefits Scheme (PBS) has a limited AI-visibility profile at 48/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (58/100) and its weakest is trust (26/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #153,032 (Tranco). The main gaps holding it back: thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Pharmaceutical Benefits Scheme (PBS) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Pharmaceutical Benefits Scheme (PBS): PayerWatch (69/100), PaceMate (69/100), Society of Pediatric Nurses (SPN) (69/100), PharmaDepot (69/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.